About Epic Care Partners in Cancer Care
"Epic Care is composed of a group of multi-disciplinary specialists to best fit your unique needs. Using new, leading technology, and our individualized approach, our patients receive specialized care from our hand-picked team of specialty providers. Epic Care centers can be found throughout the Northern California East Bay area. Services: Medical Oncology Hematology Radiation Oncology Breast Surgery Imaging – PET/CT & MRI (Including Breast) Infusion Service Research Support Services Care Providers: Medical Oncology & Hematology: Ostap Melnyk, MD, Michael, Min Yan, MD Radiation Oncology: Gopal Sachdeva, MD, Madhu Shetti, MD, Valery Uhl, MD Breast Surgery: Lisa Bailey, MD, FACS"
Clinical Trials at Epic Care Partners in Cancer Care
During the past decade, Epic Care Partners in Cancer Care conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 31 clinical trials were completed, i.e. on
average, 48.4% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 22 clinical trials were completed. i.e. 88%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Epic Care Partners in Cancer Care" #1 sponsor was "National Cancer Institute (NCI)" with 40 trials, followed by "Alliance for Clinical Trials in Oncology" with 23 trials
sponsored, "SWOG Cancer Research Network" with 18 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "NRG Oncology"
with 8 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Epic Care Partners in Cancer Care"
#1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at Epic Care Partners in Cancer Care
According to Clinical.Site data, the most researched conditions in "Epic Care Partners in Cancer Care" are
"Invasive Breast Carcinoma" (10 trials), "Breast Cancer" (7 trials), "Stage II Breast Cancer" (7 trials), "Metastatic Malignant Neoplasm in the Brain" (6 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Epic Care Partners in Cancer Care" in a lesser frequency.
Clinical Trials Intervention Types at Epic Care Partners in Cancer Care
Most popular intervention types in "Epic Care Partners in Cancer Care" are "Drug" (73 trials), "Other" (64 trials), "Biological" (33 trials), "Procedure" (26 trials) and "Radiation" (15 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (28 trials), "Quality-of-Life Assessment" (24 trials), "Questionnaire Administration" (15 trials), "Carboplatin" (11 trials) and "Computed Tomography" (11 trials). Other intervention names were less common.
Clinical Trials Genders at Epic Care Partners in Cancer Care
The vast majority of trials in "Epic Care Partners in Cancer Care" are
77 trials for "All" genders, 19 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Epic Care Partners in Cancer Care
Currently, there are NaN active trials in "Epic Care Partners in Cancer Care".
undefined are not yet recruiting,
27 are recruiting,
51 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 15 completed trials in Epic Care Partners in Cancer Care,
1 suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Epic Care Partners in Cancer Care, 0 "Phase 1"
clinical trials were conducted, 35 "Phase 2" clinical
trials and 57 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 6 trials that are defined as “Not Applicable".